The Lundbeck Foundation is an active industrial foundation created by Grete Lundbeck, widow of Hans Lundbeck, the founder of the pharmaceutical company H. Lundbeck A/S. She established the foundation in 1954 with the purpose of ensuring and expanding Lundbeck’s business, as well as providing financial support for primarily scientific objectives and the fight against diseases. Today, the Lundbeck Foundation is the largest shareholder of Lundbeck, owning 70 percent of the company.
The Lundbeck Foundation invests in research at the highest level within biomedicine and the natural sciences, focusing on research into neuroscience, psychiatry and allergology/immune modulation. The foundation provides funding for independent research through grants, recognizes young talent through prizes and fellowships, and invests in specific groundbreaking research areas through collaborative programs.